Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2015 1
2019 1
2021 1
2022 2
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
RETINAL CAPILLARY MACROANEURYSMS.
Spaide RF, Barquet LA. Spaide RF, et al. Among authors: barquet la. Retina. 2019 Oct;39(10):1889-1895. doi: 10.1097/IAE.0000000000002406. Retina. 2019. PMID: 30489449
[Role of VEGF in diseases of the retina].
Barquet LA. Barquet LA. Arch Soc Esp Oftalmol. 2015 Mar;90 Suppl 1:3-5. doi: 10.1016/S0365-6691(15)30002-2. Arch Soc Esp Oftalmol. 2015. PMID: 25925044 Review. Spanish.
Clinical Characteristics and Progression of Pachychoroid Macular Atrophy in Central Serous Chorioretinopathy.
Hasan N, Zarnegar A, Jacob N, Sahoo N, Saju S, Zhou A, Wykoff CC, Winter H, Gill M, Silva R, Pereira P, Hertkorn F, Desideri LF, Munk MR, Villafuerte-Trisolini C, Yiu G, Wu L, Chhablani J; Macula Society International CSCR Research Network – MICRoN. Hasan N, et al. Ophthalmol Retina. 2025 Oct;9(10):984-993. doi: 10.1016/j.oret.2025.04.005. Epub 2025 Apr 11. Ophthalmol Retina. 2025. PMID: 40222639
Predictors of persistent central serous chorioretinopathy: a multicenter retrospective study - MICRoN report number four.
Gandhi P, Hasan N, Gidwani K, Yang J, Cao J, Saju S, Wykoff CC, Khateb S, Kim M, Jacob N, Ashfaq Y, Kroeger Z, Zhang M, Chotcomwongse P, Ruamviboonsuk P, Winter H, Gill M, Lima LH, Wu L, Chhablani J; Macula Society International CSCR Research Network – MICRoN, MICRoN study group. Gandhi P, et al. Graefes Arch Clin Exp Ophthalmol. 2025 Oct 11. doi: 10.1007/s00417-025-06969-5. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 41074999
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes.
Zarranz-Ventura J, Parrado-Carrillo A, Nguyen V, Sararols L, Garay-Aramburu G, Puzo M, Arruabarrena C, Figueras-Roca M, Gillies MC, Casaroli-Marano RP; from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group. Zarranz-Ventura J, et al. Clin Exp Ophthalmol. 2022 Apr;50(3):312-324. doi: 10.1111/ceo.14054. Epub 2022 Feb 20. Clin Exp Ophthalmol. 2022. PMID: 35106882 Free article.
Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study.
Saenz-de-Viteri M, Recalde S, Fernandez-Robredo P, López Gálvez MI, Arias Barquet L, Figueroa MS, García-Arumí J, García-Layana A; In-Eye Study Group. Saenz-de-Viteri M, et al. Acta Ophthalmol. 2021 Dec;99(8):861-870. doi: 10.1111/aos.14786. Epub 2021 Mar 15. Acta Ophthalmol. 2021. PMID: 33720541 Free article. Clinical Trial.